drugset / Trial / NCT00607737

Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes

NCT00607737

Phase 4 Completed 40 enrolled Lise Tarnow Novo Nordisk A/S · collab
RandomizedFactorialQuadruple-blindDiagnostic

Summary

To compare application site reactions after superficial and deep subcutaneous and intradermal injections of insulin detemir and saline in patients with diabetes \- The patient serves as his own control, n=100 patients with diabetes

Timeline

Start
2008-01
Primary completion
2009-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin detemir Protein / enzyme biologic Other

Indications